Testing effectiveness (Phase 2)Ended earlyNCT01207102
What this trial is testing
Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer
Who this might be right for
Metastatic Breast Cancer
Duke University 10